Takayoshi Hidaka

447 citations
22 papers · 372 indexed · h-index 9

Takayoshi Hidaka

22 papers receiving 338 citations

Peers

Takayoshi Hidaka
Comparison fields: 5 of 79
  • Biochemistry 61
  • Toxicology 23
  • Molecular Biology 256
  • Pharmacology 58
  • Pharmacology 25
Replace Rosario I. Bello with:
Rosario I. Bello Spain
Li‐Qiang Sun United States
Shigefumi Takeda Japan
Jeffrey Sarver United States
Ralph T. Scannell United States
Osman Gani Norway
Wolf‐Dieter Lienhart Austria
Yih‐Dih Cheng Taiwan
Kajsa Norbeck Sweden
Egīls Bisenieks Latvia
Takayoshi Hidaka relative to Rosario I. Bello Spain Rosario I. Bello's profile →
Citations per field
00.5×4.5×
Rosario I. Bello · 1×
Citations per year

Countries citing papers authored by Takayoshi Hidaka

Since Specialization
Citations

This map shows the geographic impact of Takayoshi Hidaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takayoshi Hidaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takayoshi Hidaka more than expected).

Fields of papers citing papers by Takayoshi Hidaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takayoshi Hidaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takayoshi Hidaka. The network helps show where Takayoshi Hidaka may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Takayoshi Hidaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Takayoshi Hidaka Line = papers co-authored together Takayoshi Hidaka links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20109
2 2008145
3 200610
4 20033
5 199925
6 19945
7 19931
8 19924
9 19865
10 19865
11 19865
12 19855
13 198421
14 19805
15 197958
16 197912
17 19741
18 19741
19 197315
20 19735

About Takayoshi Hidaka

Takayoshi Hidaka is a scholar working on Pharmacology, Toxicology and Biochemistry, having authored 22 papers that have together received 372 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (5 papers), Fungal Plant Pathogen Control (3 papers), Biochemical and Molecular Research (3 papers), Cancer Research and Treatments (2 papers), Coenzyme Q10 studies and effects (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (2 papers), Plant Disease Resistance and Genetics (2 papers) and Natural product bioactivities and synthesis (2 papers). The work is most often cited by research in Biochemistry (61 citations), Toxicology (23 citations) and Molecular Biology (256 citations). Takayoshi Hidaka has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Kazunori Hosoe, Kenji Fujii, Toshiaki Yamashita, Kiyoshi Watanabe, HAMAO UMEZAWA, TOMIO TAKEUCHI, Mitsuaki Kitano, Hideo Kondo, Robert L. Hall and Thomas E. Palmer. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Biochemical and Biophysical Research Communications and Biochemical Society Transactions.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026